Can We Use Terminalia Arjuna (Roxb.) Wight and Arn in Place of Novel Oral Anticoagulants (NOACs) in Post-COVID-19 Cardiac Conditions? | Journal of Pharmacology and Pharmacotherapeutics; 13(1):95-96, 2022. | EMBASE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Can We Use Terminalia Arjuna (Roxb.) Wight and Arn in Place of Novel Oral Anticoagulants (NOACs) in Post-COVID-19 Cardiac Conditions?

Dwivedi, S.; Sharma, V.; Patil, C. R..

Journal of Pharmacology and Pharmacotherapeutics ; 13(1):95-96, 2022.

Article in English | EMBASE | ID: covidwho-1916510

Keywords

coronavirus disease 2019; heart; human; letter; nonhuman; Terminalia arjuna; anticoagulant agent

Search on Google

Full text: Available Collection: Databases of international organizations Database: EMBASE Topics: Long Covid Language: English Journal: Journal of Pharmacology and Pharmacotherapeutics Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: Databases of international organizations Database: EMBASE Topics: Long Covid Language: English Journal: Journal of Pharmacology and Pharmacotherapeutics Year: 2022 Document Type: Article